Related Experiment Videos
Aberrant activation of JAK/STAT pathway components in response to G-CSF, interferon-alpha/beta and interferon-gamma
U Novak1, A C Ward, P J Hertzog
1University of Melbourne, Dept. of Medicine, Royal Melbourne Hospital, Parkville, Australia.
Abstract:
There is evidence that the cellular responses to cytokines, such as granulocyte colony stimulating factor (G-CSF) and interferons, depend on prior activation of components of the JAK/STAT signalling pathway. We report here that the myeloid cell line NFS-60 shows aberrant JAK/STAT signalling yet elicits expected biological responses to G-CSF and interferons-alpha/beta and gamma. Instead of increased phosphorylation of JAK1 and JAK2 in response to G-CSF and interferon-gamma, and JAK1 and Tyk2 in response to interferon-alpha/beta, we observed only an increase of phosphorylation of Tyk2 in response to all of these cytokines in NFS-60 cells. The subset of STAT proteins being activated in response to these cytokines was unusual as well. G-CSF activated STAT3 and STAT5A, whereas interferons activated, in addition to STAT1 and STAT5 other, as yet unidentified, DNA binding proteins. However, NFS-60 cells show normal biological responses to these cytokines, such as proliferation in response to G-CSF, and reduction of proliferation, induction of an anti-viral response and induction of specific genes in response to interferons.
Insights
Cellular responses to cytokines like G-CSF and interferons typically rely on JAK/STAT signaling. However, NFS-60 cells exhibit unusual JAK/STAT activation yet respond normally, suggesting alternative signaling pathways.
Area of Science:
- Cellular Biology
- Immunology
- Molecular Biology
Background:
- Cytokine signaling, including granulocyte colony-stimulating factor (G-CSF) and interferons, is crucial for cellular responses.
- The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a key mediator of these cytokine-induced cellular responses.
- Prior activation of JAK/STAT pathway components is generally considered essential for cellular responsiveness to cytokines.
Purpose of the Study:
- To investigate the JAK/STAT signaling pathway activation in the myeloid cell line NFS-60 in response to G-CSF and interferons.
- To determine if aberrant JAK/STAT signaling in NFS-60 cells affects their biological responses to these cytokines.
- To identify the specific JAK and STAT proteins activated by G-CSF and interferons in NFS-60 cells.
Main Methods:
- Utilized NFS-60 myeloid cell line.
- Stimulated cells with granulocyte colony-stimulating factor (G-CSF), interferon-alpha/beta, and interferon-gamma.
- Analyzed protein phosphorylation of JAK kinases (JAK1, JAK2, Tyk2) and STAT proteins using techniques such as Western blotting or phospho-specific antibodies.
- Assessed biological responses including cell proliferation, anti-viral response induction, and gene expression.
Main Results:
- NFS-60 cells displayed aberrant JAK/STAT signaling, with only Tyk2 phosphorylation observed in response to G-CSF and interferons, unlike typical JAK1/JAK2 or JAK1/Tyk2 activation.
- Specific STAT protein activation patterns were unusual: G-CSF activated STAT3 and STAT5A, while interferons activated STAT1, STAT5, and other unidentified DNA-binding proteins.
- Despite the aberrant signaling, NFS-60 cells exhibited normal biological responses to G-CSF (proliferation) and interferons (reduced proliferation, anti-viral response, gene induction).
Conclusions:
- NFS-60 cells demonstrate that normal biological responses to G-CSF and interferons can occur despite atypical JAK/STAT pathway activation.
- The findings suggest the existence of alternative or compensatory signaling mechanisms that bypass canonical JAK/STAT activation patterns.
- Further research is needed to elucidate the precise molecular mechanisms underlying these observed cellular responses in NFS-60 cells.